Atea Pharmaceuticals (NASDAQ:AVIR) will release its quarterly earnings report on Thursday, 2026-03-05. Here’s a brief overview for investors ahead of the announcement.
Analysts anticipate Atea Pharmaceuticals to report an earnings per share (EPS) of $-0.48.
The market awaits Atea Pharmaceuticals’s announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It’s important for new investors to understand that guidance can be a significant driver of stock prices.
Past Earnings Performance
During the last quarter, the company reported an EPS missed by $0.10, …